A retrospective analysis of pharmacokinetic/pharmacodynamic indices as indicators of the clinical efficacy of ciprofloxacin

被引:20
|
作者
Sánchez-Recio, MM [1 ]
Colino, CI [1 ]
Sánchez-Navarro, A [1 ]
机构
[1] Univ Salamanca, Fac Farm, Dept Farm & Tecnol Farmaceut, E-37007 Salamanca, Spain
关键词
D O I
10.1093/jac/45.3.321
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A retrospective analysis of the relationship between estimated pharmacokinetic/pharmacodynamic indices and the reported efficacy of ciprofloxacin has been carried out using different correlation models. C-max(SS)/MIC, T-SS > MIC, (AUC(SS))/MIC and AUIC(SS) were calculated for each clinical case included in the study, from simulated plasma level curves corresponding to the dosage regimen administered. A univariate correlation analysis was performed considering efficacy (%) as the dependent variable and indices as the independent variables according to linear and non-linear pharmacokinetic-pharmacodynamic models (PK-PD models),The results prove that log-transformation of the independent variable improves the data fitting to linear model. The four estimated indices show a log-linear relationship with outcome, T-SS > MIC and AUIC(SS) being the parameters best correlated with percentage efficacy. The E-max model with intrinsic response is an additional correlation strategy for T-SS > MIG, leading to estimated values of E-max and E-0 of 100.34 +/- 25.09% and 24.40 +/- 11.7%, respectively. The wide range of bacteria responsible for the infections considered, including Gram-positive pathogens such as staphylococci, might explain the good correlation between T-SS > MIC and percentage efficacy found for ciprofloxacin in this study.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 50 条
  • [31] Clinical application of pharmacokinetic and pharmacodynamic models
    Billard, V
    ADVANCES IN MODELLING AND CLINICAL APPLICATION OF INTRAVENOUS ANAESTHESIA, 2003, 523 : 57 - 70
  • [32] Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
    Mueck, Wolfgang
    Stampfuss, Jan
    Kubitza, Dagmar
    Becka, Michael
    CLINICAL PHARMACOKINETICS, 2014, 53 (01) : 1 - 16
  • [33] Cerebrospinal pharmacokinetic and pharmacodynamic analysis of efficacy of meropenem in paediatric patients with bacterial meningitis
    Ohata, Yuka
    Tomita, Yoshiko
    Sunakawa, Keisuke
    Drusano, George L.
    Tanigawara, Yusuke
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (03) : 292 - 300
  • [34] ZalcitabineAn Update of Its Pharmacodynamic and Pharmacokinetic Properties and Clinical Efficacy in the Management of HIV Infection
    Julie C. Adkins
    David H. Peters
    Diana Faulds
    Drugs, 1997, 53 : 1054 - 1080
  • [35] Pharmacokinetics of ciprofloxacin in the human eye: A clinical study and population pharmacokinetic analysis
    Morlet, N
    Graham, GG
    Gatus, B
    McLachlan, AJ
    Salonikas, C
    Naidoo, D
    Goldberg, I
    Lam, CM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) : 1674 - 1679
  • [36] Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis:: Evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy
    Shandil, Radha K.
    Jayaram, Ramesh
    Kaur, Parvinder
    Gaonkar, Sheshagiri
    Suresh, B. L.
    Mahesh, B. N.
    Jayashree, R.
    Nandi, Vrinda
    Bharath, Sowmya
    Balasubramanian, V.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) : 576 - 582
  • [37] Zalcitabine - An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection
    Adkins, JC
    Peters, DH
    Faulds, D
    DRUGS, 1997, 53 (06) : 1054 - 1080
  • [38] Mycophenolate mofetil - A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation
    Fulton, B
    Markham, A
    DRUGS, 1996, 51 (02) : 278 - 298
  • [39] Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasis
    Ng, CM
    Joshi, A
    Dedrick, RL
    Garovoy, MR
    Bauer, RJ
    PHARMACEUTICAL RESEARCH, 2005, 22 (07) : 1088 - 1100
  • [40] Pharmacokinetic-pharmacodynamic integration of enrofloxacin and its metabolite ciprofloxacin in buffalo calves
    Daundkar, Prashant S.
    Vemu, Bhaskar
    Dumka, Vinod K.
    Sharma, Suresh K.
    VETERINARY MEDICINE AND SCIENCE, 2015, 1 (02): : 63 - 71